spacer
spacer

Jump to: InterProScan Databases Documentation FTP site Help Advanced search

InterPro: IPR002156 Ribonuclease H

Protein matchesHelp
UniProtKB
Matches:
10754 proteins
AccessionHelp IPR002156 RNase_H
TypeHelp Domain
SignaturesHelp
InterPro RelationshipsHelp
Parent IPR012337 Polynucleotidyl transferase, ribonuclease H fold
Found in IPR014636 RNase H, phosphoglycerate mutase domain-containing
IPR017067 Ribonuclease H1, eukaryote
GO Term annotationHelp
Function GO:0003676 nucleic acid binding
GO:0004523 ribonuclease H activity
InterPro annotation
BioMart Logo Entry Details in BioMart
AbstractHelp

The RNase H domain is responsible for hydrolysis of the RNA portion of RNA x DNA hybrids, and this activity requires the presence of divalent cations (Mg2+ or Mn2+) that bind its active site. This domain is a part of a large family of homologous RNase H enzymes of which the RNase HI protein from Escherichia coli is the best characterised [1]. Secondary structure predictions for the enzymes from E. coli, yeast, human liver and diverse retroviruses (such as Rous sarcoma virus and the Foamy viruses) supported, in every case, the five beta-strands (1 to 5) and four or five alpha-helices (A, B/C, D, E) that have been identified by crystallography in the RNase H domain of Human immunodeficiency virus 1 (HIV-1) reverse transcriptase and in E. coli RNase H [2]. Reverse transcriptase (RT) is a modular enzyme carrying polymerase and ribonuclease H (RNase H) activities in separable domains. Reverse transcriptase (RT) converts the single-stranded RNA genome of a retrovirus into a double-stranded DNA copy for integration into the host genome. This process requires ribonuclease H as well as RNA- and DNA-directed DNA polymerase activities.

Retroviral RNase H is synthesised as part of the POL polyprotein that contains; an aspartyl protease, a reverse transcriptase, RNase H and integrase. POL polyprotein undergoes specific enzymatic cleavage to yield the mature proteins. Bacterial RNase H EC:3.1.26.4 catalyses endonucleolytic cleavage to 5'-phosphomonoester acting on RNA-DNA hybrids.

The 3D structure of the RNase H domain from diverse bacteria and retroviruses has been solved [3, 4, 5]. All have four beta strands and four to five alpha helices. The E. coli RNase H1 protein binds a single Mg2+ ion cofactor in the active site of the enzyme. The divalent cation is bound by the carboxyl groups of four acidic residues, Asp-10, Glu-48, Asp-70, and Asp-134 [4]. The first three acidic residues are highly conserved in all bacterial and retroviral RNase H sequences.

Structural linksHelp
PDB - click here
Database linksHelp
Enzyme: EC:3.1.26.4
PROSITE doc: PDOC50879
PANDIT: PF00075
Blocks: IPB002156
Pfam Clan: CL0219.10

Taxonomic coverageHelp

Overlapping InterPro entriesHelp
IPR002156 Numbers of overlapping proteins Average numbers of overlapping amino acids

Example proteinsHelp
O60930 Ribonuclease H1

O70338 Ribonuclease H1

P0C2F6 Putative ribonuclease H protein At1g65750

Q04740 Ribonuclease H

Q55801 Ribonuclease HI

More proteins


Example Proteins Key


InterPro entry accession number/name and structure databases Colour code
IPR015706 RNA-directed DNA polymerase (reverse transcriptase), related
IPR002156 Ribonuclease H
IPR009027 Ribosomal protein L9/RNase H1, N-terminal
IPR011320 Ribonuclease H1, N-terminal
IPR017067 Ribonuclease H1, eukaryote
IPR012337 Polynucleotidyl transferase, ribonuclease H fold
SWISS-MODEL
PDB Chain
ModBase
SCOP Domain
CATH Domain

PublicationsHelp
1. Goedken ER, Marqusee S.
Folding the ribonuclease H domain of Moloney murine leukemia virus reverse transcriptase requires metal binding or a short N-terminal extension.
Proteins 33 135-43 1998 [PubMed: 9741851]
http://dx.doi.org/10.1002/(SICI)1097-0134(19981001)33:1<135::AID-PROT12>3.3.CO;2-K
2. Ey PL, Freeman NL, Bela B, Haese PM, Li P, McInnes JL.
Sequence and comparative structural analysis of the murine leukaemia virus amphotropic strain 4070A RNase H domain.
Arch. Virol. 144 2185-99 1999 [PubMed: 10603172]
http://dx.doi.org/10.1007/s007050050632
3. Yang W, Hendrickson WA, Crouch RJ, Satow Y.
Structure of ribonuclease H phased at 2 A resolution by MAD analysis of the selenomethionyl protein.
Science 249 1398-405 1990 [PubMed: 2169648]
http://www.sciencemag.org/cgi/content/abstract/249/4975/1398
4. Katayanagi K, Okumura M, Morikawa K.
Crystal structure of Escherichia coli RNase HI in complex with Mg2+ at 2.8 A resolution: proof for a single Mg(2+)-binding site.
Proteins 17 337-46 1993 [PubMed: 8108376]
http://dx.doi.org/10.1002/prot.340170402
5. Davies JF 2nd, Hostomska Z, Hostomsky Z, Jordan SR, Matthews DA.
Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase.
Science 252 88-95 1991 [PubMed: 1707186]
http://www.sciencemag.org/cgi/content/abstract/252/5002/88

Additional ReadingHelp
Cerritelli SM, Frolova EG, Feng C, Grinberg A, Love PE, Crouch RJ.
Failure to produce mitochondrial DNA results in embryonic lethality in Rnaseh1 null mice.
Mol. Cell 11 2003 807-15 [PubMed: 12667461]
http://dx.doi.org/10.1016/S1097-2765(03)00088-1
Tucker TJ, Saggar S, Sisko JT, Tynebor RM, Williams TM, Felock PJ, Flynn JA, Lai MT, Liang Y, McGaughey G, Liu M, Miller M, Moyer G, Munshi V, Perlow-Poehnelt R, Prasad S, Sanchez R, Torrent M, Vacca JP, Wan BL, Yan Y.
The design and synthesis of diaryl ether second generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) with enhanced potency versus key clinical mutations.
Bioorg. Med. Chem. Lett. 18 2008 2959-66 [PubMed: 18396399]
http://dx.doi.org/10.1016/j.bmcl.2008.03.064
Crouch RJ.
Ribonuclease H: from discovery to 3D structure.
New Biol. 2 1990 771-7 [PubMed: 2177653]
Dasgupta S, Masukata H, Tomizawa J.
Multiple mechanisms for initiation of ColE1 DNA replication: DNA synthesis in the presence and absence of ribonuclease H.
Cell 51 1987 1113-22 [PubMed: 2446774]
http://dx.doi.org/10.1016/0092-8674(87)90597-6
Bauman JD, Das K, Ho WC, Baweja M, Himmel DM, Clark AD Jr, Oren DA, Boyer PL, Hughes SH, Shatkin AJ, Arnold E.
Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design.
Nucleic Acids Res. 36 2008 5083-92 [PubMed: 18676450]
http://dx.doi.org/10.1093/nar/gkn464
Tucker TJ, Sisko JT, Tynebor RM, Williams TM, Felock PJ, Flynn JA, Lai MT, Liang Y, McGaughey G, Liu M, Miller M, Moyer G, Munshi V, Perlow-Poehnelt R, Prasad S, Reid JC, Sanchez R, Torrent M, Vacca JP, Wan BL, Yan Y.
Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant viruses.
J. Med. Chem. 51 2008 6503-11 [PubMed: 18826204]
http://dx.doi.org/10.1021/jm800856c
Spallarossa A, Cesarini S, Ranise A, Ponassi M, Unge T, Bolognesi M.
Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhibitors.
Biochem. Biophys. Res. Commun. 365 2008 764-70 [PubMed: 18035053]
http://dx.doi.org/10.1016/j.bbrc.2007.11.036
Zhao Z, Wolkenberg SE, Lu M, Munshi V, Moyer G, Feng M, Carella AV, Ecto LT, Gabryelski LJ, Lai MT, Prasad SG, Yan Y, McGaughey GB, Miller MD, Lindsley CW, Hartman GD, Vacca JP, Williams TM.
Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs).
Bioorg. Med. Chem. Lett. 18 2008 554-9 [PubMed: 18083561]
http://dx.doi.org/10.1016/j.bmcl.2007.11.085
spacer
spacer
InterPro 23.1